{
    "2020-02-07": [
        [
            {
                "time": "",
                "original_text": "增收不增利 沃森生物2019年业绩降86% 盈利能力下降",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "2019年",
                        "业绩下降",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "扭亏后业绩又大幅下滑 沃森药业国际化战略会不会受阻？ 盈利能力下降",
                "features": {
                    "keywords": [
                        "扭亏",
                        "业绩下滑",
                        "沃森药业",
                        "国际化战略",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}